MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin

作     者：Xiang-Liang Zhang Hui-Juan Shi Ji-Ping Wang Hong-Sheng Tang Yin-Bing Wu Zhi-Yuan Fang Shu-Zhong Cui Lian-Tang Wang 

作者机构：Department of Abdominal Surgery (Section 2) Affiliated Tumor Hospital of Guangzhou Medical College Department of PathologyThe First Affiliated Hospital of Sun Yat-Sen University Department of Surgery Brigham and Women’s Hospital and Harvard Medical School Massachusetts General Hospital and Harvard Medical School Boston MA 02114 United States 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2014年第20卷第32期

页      面：11347-11355页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：Supported by The PhD Start-up Funds of Guangzhou Medical College,Guangdong Province,China,No.2012C66 and No.2012C69 Guangdong Province Natural Science Fund,No.S2013010016662 the National Natural Science Foundation of China,No.81201932 and No.81372493 

主　　题：Advanced gastric cancer Cytoreductive surgery Hyperthermic intraperitoneal chemotherapy miR-218 Multi-drug resistance MicroRNA 

摘      要：AIM: To investigate the molecular mechanisms of miRNA in advanced gastric cancers (AGCs) before and after cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC).